Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
Biological therapy consists of using a living organism substance derived either from living organisms or laboratory produced variations of the substances to treat a particular disease. Biological therapies generally comprise interleukins, interferons, monoclonal antibodies, vaccines and so on. Biological therapy utilizes the body’s immune system either directly or indirectly in order to fight cancer. Some biological therapies for cancer use vaccines or bacteria to stimulate the body’s immune system to act against cancer cells where as some therapies involve antibodies. North America dominates a major share of the global Cancer Biological Therapy market
On the other hand, Asia pacific is projected to develop at a highest rate owing to growingoccurrence of cancer, large patient pool, improving healthcare facilities, etc.
This report elaborates on the current development of the Cancer Biological Therapy industry thoroughly based on the international market dynamics and China's market situation.
For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.
Secondly, this report lists the major players in the industry, displaying their market positions and strengths and weaknesses of their products, picturing the current competitive situation of the whole market.
Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.
By Player:
ELI Lilly
AstraZeneca, Plc
Seattle Genetics
Roche
GlaxoSmithKline
Takeda Pharmaceuticals
Pfizer
Spectrum Pharmaceuticals
Merck
Abbvie
Novartis International
Bristol-Myers Squibb
Eisai
Incyte
Sanofi
Amgen
By Type:
Monoclonal Antibodies
Blood Cell Growth Factors
Vaccines
Cancer Growth Blockers
By Application:
Hospitals
Diagnostic Laboratories
Pharmaceutical & Biotechnology Companies
Research & Academic Laboratories
By Research Region:
-
North China
-
Central China
-
South China
-
East China
-
Northeast China
-
Southwest China
-
Northwest China
TABLE OF CONTENT
Chapter 1 China Cancer Biological Therapy Market Overview 2018-2029
-
1.1 China Cancer Biological Therapy Industry Development Overview
-
1.2 China Cancer Biological Therapy Industry Development History
-
1.3 China Cancer Biological Therapy Industry Market Size (2018-2029)
-
1.4 China Cancer Biological Therapy Market Analysis by Type from Production Side
-
1.4.1 China Cancer Biological Therapy Production Volume, Production Value and Growth Rate of Monoclonal Antibodies (2018-2029)
-
1.4.2 China Cancer Biological Therapy Production Volume, Production Value and Growth Rate of Blood Cell Growth Factors (2018-2029)
-
1.4.3 China Cancer Biological Therapy Production Volume, Production Value and Growth Rate of Vaccines (2018-2029)
-
1.4.4 China Cancer Biological Therapy Production Volume, Production Value and Growth Rate of Cancer Growth Blockers (2018-2029)
-
1.5 China Cancer Biological Therapy Market Analysis by Application from Consumption End
-
1.5.1 China Cancer Biological Therapy Sales Volume, Sales Value and Growth Rate of Hospitals (2018-2029)
-
1.5.2 China Cancer Biological Therapy Sales Volume, Sales Value and Growth Rate of Diagnostic Laboratories (2018-2029)
-
1.5.3 China Cancer Biological Therapy Sales Volume, Sales Value and Growth Rate of Pharmaceutical & Biotechnology Companies (2018-2029)
-
1.5.4 China Cancer Biological Therapy Sales Volume, Sales Value and Growth Rate of Research & Academic Laboratories (2018-2029)
-
1.6 China Cancer Biological Therapy Market Analysis by Region
-
1.6.1 North China Cancer Biological Therapy Market Size and Growth Rate from 2018-2029
-
1.6.2 Central China Cancer Biological Therapy Market Size and Growth Rate from 2018-2029
-
1.6.3 South China Cancer Biological Therapy Market Size and Growth Rate from 2018-2029
-
1.6.4 East China Cancer Biological Therapy Market Size and Growth Rate from 2018-2029
-
1.6.5 Northeast China Cancer Biological Therapy Market Size and Growth Rate from 2018-2029
-
1.6.6 Southwest China Cancer Biological Therapy Market Size and Growth Rate from 2018-2029
-
1.6.7 Northwest China Cancer Biological Therapy Market Size and Growth Rate from 2018-2029
Chapter 2 China Cancer Biological Therapy Industry Development Environment
-
2.1 Industry Development Environment Analysis
-
2.1.1 Industry Technological Progress Analysis
-
2.1.2 Industrial Organizational Innovation Analysis
-
2.1.3 Changes in Social Habits
-
2.1.4 Alterations in Government Policies
-
2.1.5 Impact of Economic Globalization
-
2.2 Domestic and Foreign Industry Competition Analysis
-
2.2.1 Comparative Analysis on Cancer Biological Therapy Market Status and Competition at home and abroad in 2023
-
2.2.2 China Cancer Biological Therapy Market Status and Competition Analysis in 2023
-
2.2.3 China Cancer Biological Therapy Market Concentration Analysis in 2023
-
2.3 Problems and Countermeasures in the development of China Cancer Biological Therapy Industry
-
2.3.1 Industry Development Constraints
-
2.3.2 Industry Development Considerations
-
2.3.3 Suggestions on Industry Development Measures
-
2.3.4 Development Strategies for SMEs
-
2.4 Influence of COVID-19 Outbreak on Cancer Biological Therapy Industry Development
Chapter 3 Cancer Biological TherapyIndustry Chain Analysis
-
3.1 Cancer Biological Therapy Industry Chain
-
3.2 Cancer Biological Therapy Upstream Industry Analysis
-
3.2.1 Upstream Industry Development Status
-
3.2.2 Upstream Industry Development Forecast
-
3.2.3 Impact of Upstream Industry on the Cancer Biological Therapy Market
-
3.3 Cancer Biological Therapy Downstream Industry Analysis
-
3.3.1 Downstream Industry Development Status
-
3.3.2 Downstream Industry Development Forecast
-
3.3.3 Impact of Downstream Industry on the Cancer Biological Therapy Market
Chapter 4 China Cancer Biological Therapy Market, by Type
-
4.1 China Cancer Biological Therapy Market Trend, by Type
-
4.2 Product Types of Major Suppliers
-
4.3 Competitive Landscape of Major Types
-
4.4 China Cancer Biological Therapy Total Production Volume and Growth Rate from Production Side
-
4.5 China Cancer Biological Therapy Production Volume and Growth Rate, by Type
-
4.5.1 China Cancer Biological Therapy Production Volume and Growth Rate of Monoclonal Antibodies
-
4.5.2 China Cancer Biological Therapy Production Volume and Growth Rate of Blood Cell Growth Factors
-
4.5.3 China Cancer Biological Therapy Production Volume and Growth Rate of Vaccines
-
4.5.4 China Cancer Biological Therapy Production Volume and Growth Rate of Cancer Growth Blockers
Chapter 5 China Cancer Biological Therapy Market, by Application
-
5.1 Downstream Market Overview
-
5.2 Competitive Landscape of Major Applications
-
5.3 Market Potential Analysis, by Application
-
5.4 China Cancer Biological Therapy Total Market Size and Growth Rate from Consumption End
-
5.5 China Cancer Biological Therapy Market Size and Growth Rate, by Application
-
5.5.1 China Cancer Biological Therapy Market Size and Growth Rate of Hospitals
-
5.5.2 China Cancer Biological Therapy Market Size and Growth Rate of Diagnostic Laboratories
-
5.5.3 China Cancer Biological Therapy Market Size and Growth Rate of Pharmaceutical & Biotechnology Companies
-
5.5.4 China Cancer Biological Therapy Market Size and Growth Rate of Research & Academic Laboratories
Chapter 6 China Cancer Biological Therapy Market, by Region
-
6.1 China Cancer Biological Therapy Production Volume and Production Value, by Region
-
6.2 China Cancer Biological Therapy Sales Volume and Sales Value, by Region
Chapter 7 North China Cancer Biological Therapy Market Analysis
-
7.1 North China Cancer Biological Therapy Market, by Type
-
7.2 North China Cancer Biological Therapy Market, by Application
Chapter 8 Central China Cancer Biological Therapy Market Analysis
-
8.1 Central China Cancer Biological Therapy Market, by Type
-
8.2 Central China Cancer Biological Therapy Market, by Application
Chapter 9 South China Cancer Biological Therapy Market Analysis
-
9.1 South China Cancer Biological Therapy Market, by Type
-
9.2 South China Cancer Biological Therapy Market, by Application
Chapter 10 East China Cancer Biological Therapy Market Analysis
-
10.1 East China Cancer Biological Therapy Market, by Type
-
10.2 East China Cancer Biological Therapy Market, by Application
Chapter 11 Northeast China Cancer Biological Therapy Market Analysis
-
11.1 Northeast China Cancer Biological Therapy Market, by Type
-
11.2 Northeast China Cancer Biological Therapy Market, by Application
Chapter 12 Southwest China Cancer Biological Therapy Market Analysis
-
12.1 Southwest China Cancer Biological Therapy Market, by Type
-
12.2 Southwest China Cancer Biological Therapy Market, by Application
Chapter 13 Northwest China Cancer Biological Therapy Market Analysis
-
13.1 Northwest China Cancer Biological Therapy Market, by Type
-
13.2 Northwest China Cancer Biological Therapy Market, by Application
Chapter 14 Company Profiles
-
14.1 ELI Lilly
-
14.1.1 ELI Lilly Company Profile
-
14.1.2 ELI Lilly Cancer Biological Therapy Market Performance
-
14.1.3 Product&Service Introduction
-
14.2 AstraZeneca, Plc
-
14.2.1 AstraZeneca, Plc Company Profile
-
14.2.2 AstraZeneca, Plc Cancer Biological Therapy Market Performance
-
14.2.3 Product&Service Introduction
-
14.3 Seattle Genetics
-
14.3.1 Seattle Genetics Company Profile
-
14.3.2 Seattle Genetics Cancer Biological Therapy Market Performance
-
14.3.3 Product&Service Introduction
-
14.4 Roche
-
14.4.1 Roche Company Profile
-
14.4.2 Roche Cancer Biological Therapy Market Performance
-
14.4.3 Product&Service Introduction
-
14.5 GlaxoSmithKline
-
14.5.1 GlaxoSmithKline Company Profile
-
14.5.2 GlaxoSmithKline Cancer Biological Therapy Market Performance
-
14.5.3 Product&Service Introduction
-
14.6 Takeda Pharmaceuticals
-
14.6.1 Takeda Pharmaceuticals Company Profile
-
14.6.2 Takeda Pharmaceuticals Cancer Biological Therapy Market Performance
-
14.6.3 Product&Service Introduction
-
14.7 Pfizer
-
14.7.1 Pfizer Company Profile
-
14.7.2 Pfizer Cancer Biological Therapy Market Performance
-
14.7.3 Product&Service Introduction
-
14.8 Spectrum Pharmaceuticals
-
14.8.1 Spectrum Pharmaceuticals Company Profile
-
14.8.2 Spectrum Pharmaceuticals Cancer Biological Therapy Market Performance
-
14.8.3 Product&Service Introduction
-
14.9 Merck
-
14.9.1 Merck Company Profile
-
14.9.2 Merck Cancer Biological Therapy Market Performance
-
14.9.3 Product&Service Introduction
-
14.10 Abbvie
-
14.10.1 Abbvie Company Profile
-
14.10.2 Abbvie Cancer Biological Therapy Market Performance
-
14.10.3 Product&Service Introduction
-
14.11 Novartis International
-
14.11.1 Novartis International Company Profile
-
14.11.2 Novartis International Cancer Biological Therapy Market Performance
-
14.11.3 Product&Service Introduction
-
14.12 Bristol-Myers Squibb
-
14.12.1 Bristol-Myers Squibb Company Profile
-
14.12.2 Bristol-Myers Squibb Cancer Biological Therapy Market Performance
-
14.12.3 Product&Service Introduction
-
14.13 Eisai
-
14.13.1 Eisai Company Profile
-
14.13.2 Eisai Cancer Biological Therapy Market Performance
-
14.13.3 Product&Service Introduction
-
14.14 Incyte
-
14.14.1 Incyte Company Profile
-
14.14.2 Incyte Cancer Biological Therapy Market Performance
-
14.14.3 Product&Service Introduction
-
14.15 Sanofi
-
14.15.1 Sanofi Company Profile
-
14.15.2 Sanofi Cancer Biological Therapy Market Performance
-
14.15.3 Product&Service Introduction
-
14.16 Amgen
-
14.16.1 Amgen Company Profile
-
14.16.2 Amgen Cancer Biological Therapy Market Performance
-
14.16.3 Product&Service Introduction
Chapter 15 Research Conclusions and Investment Suggestions
-
15.1 Cancer Biological Therapy Industry Research Conclusions
-
15.2 Cancer Biological Therapy Industry Investment Suggestions
-
15.2.1 Suggestions on Industry Development Strategy
-
15.2.2 Suggestions on Industry Investment Direction
-
15.2.3 Suggestions on Industry Investment Strategy
List of Tables and Figures
-
Figure China Cancer Biological Therapy Industry Market Size (2018-2029)
-
Figure China Cancer Biological Therapy Production Volume, Production Value and Growth Rate of Monoclonal Antibodies (2018-2029)
-
Figure China Cancer Biological Therapy Production Volume, Production Value and Growth Rate of Blood Cell Growth Factors (2018-2029)
-
Figure China Cancer Biological Therapy Production Volume, Production Value and Growth Rate of Vaccines (2018-2029)
-
Figure China Cancer Biological Therapy Production Volume, Production Value and Growth Rate of Cancer Growth Blockers (2018-2029)
-
Figure China Cancer Biological Therapy Sales Volume, Sales Value and Growth Rate of Hospitals (2018-2029)
-
Figure China Cancer Biological Therapy Sales Volume, Sales Value and Growth Rate of Diagnostic Laboratories (2018-2029)
-
Figure China Cancer Biological Therapy Sales Volume, Sales Value and Growth Rate of Pharmaceutical & Biotechnology Companies (2018-2029)
-
Figure China Cancer Biological Therapy Sales Volume, Sales Value and Growth Rate of Research & Academic Laboratories (2018-2029)
-
Figure North China Cancer Biological Therapy Market Size and Growth Rate from 2018-2029
-
Figure Central China Cancer Biological Therapy Market Size and Growth Rate from 2018-2029
-
Figure South China Cancer Biological Therapy Market Size and Growth Rate from 2018-2029
-
Figure East China Cancer Biological Therapy Market Size and Growth Rate from 2018-2029
-
Figure Northeast China Cancer Biological Therapy Market Size and Growth Rate from 2018-2029
-
Figure Southwest China Cancer Biological Therapy Market Size and Growth Rate from 2018-2029
-
Figure Northwest China Cancer Biological Therapy Market Size and Growth Rate from 2018-2029
-
Figure Cancer Biological Therapy Industry Chain
-
Table Product Types of Major Suppliers in 2023
-
Figure China Cancer Biological Therapy Market Share by Type in 2018
-
Figure China Cancer Biological Therapy Market Share by Type in 2023
-
Figure China Cancer Biological Therapy Total Production Volume and Growth Rate from Production Side (2018-2023)
-
Figure China Cancer Biological Therapy Production Volume and Growth Rate of Monoclonal Antibodies (2018-2023)
-
Figure China Cancer Biological Therapy Production Volume and Growth Rate of Blood Cell Growth Factors (2018-2023)
-
Figure China Cancer Biological Therapy Production Volume and Growth Rate of Vaccines (2018-2023)
-
Figure China Cancer Biological Therapy Production Volume and Growth Rate of Cancer Growth Blockers (2018-2023)
-
Figure China Cancer Biological Therapy Market Share by Application in 2018
-
Figure China Cancer Biological Therapy Market Share by Application in 2023
-
Figure China Cancer Biological Therapy Total Market Size and Growth Rate from Consumption End
-
Figure China Cancer Biological Therapy Market Size and Growth Rate of Hospitals (2018-2023)
-
Figure China Cancer Biological Therapy Market Size and Growth Rate of Diagnostic Laboratories (2018-2023)
-
Figure China Cancer Biological Therapy Market Size and Growth Rate of Pharmaceutical & Biotechnology Companies (2018-2023)
-
Figure China Cancer Biological Therapy Market Size and Growth Rate of Research & Academic Laboratories (2018-2023)
-
Table China Cancer Biological Therapy Production Volume by Region (2018-2023)
-
Table China Cancer Biological Therapy Production Volume Share by Region (2018-2023)
-
Figure China Cancer Biological Therapy Production Volume Share by Region (2018-2023)
-
Table China Cancer Biological Therapy Production Value by Region (2018-2023)
-
Table China Cancer Biological Therapy Production Value Share by Region (2018-2023)
-
Figure China Cancer Biological Therapy Production Value Share by Region (2018-2023)
-
Table China Cancer Biological Therapy Sales Volume by Region (2018-2023)
-
Table China Cancer Biological Therapy Sales Volume Share by Region (2018-2023)
-
Figure China Cancer Biological Therapy Sales Volume Share by Region (2018-2023)
-
Table China Cancer Biological Therapy Sales Value by Region (2018-2023)
-
Table China Cancer Biological Therapy Sales Value Share by Region (2018-2023)
-
Figure China Cancer Biological Therapy Sales Value Share by Region (2018-2023)
-
Table North China Cancer Biological Therapy Production Volume by Type (2018-2023)
-
Table North China Cancer Biological Therapy Production Volume Share by Type (2018-2023)
-
Figure North China Cancer Biological Therapy Production Volume Share by Type (2018-2023)
-
Table North China Cancer Biological Therapy Sales Volume by Application (2018-2023)
-
Table North China Cancer Biological Therapy Sales Volume Share by Application (2018-2023)
-
Figure North China Cancer Biological Therapy Sales Volume Share by Application (2018-2023)
-
Table Central China Cancer Biological Therapy Production Volume by Type (2018-2023)
-
Table Central China Cancer Biological Therapy Production Volume Share by Type (2018-2023)
-
Figure Central China Cancer Biological Therapy Production Volume Share by Type (2018-2023)
-
Table Central China Cancer Biological Therapy Sales Volume by Application (2018-2023)
-
Table Central China Cancer Biological Therapy Sales Volume Share by Application (2018-2023)
-
Figure Central China Cancer Biological Therapy Sales Volume Share by Application (2018-2023)
-
Table South China Cancer Biological Therapy Production Volume by Type (2018-2023)
-
Table South China Cancer Biological Therapy Production Volume Share by Type (2018-2023)
-
Figure South China Cancer Biological Therapy Production Volume Share by Type (2018-2023)
-
Table South China Cancer Biological Therapy Sales Volume by Application (2018-2023)
-
Table South China Cancer Biological Therapy Sales Volume Share by Application (2018-2023)
-
Figure South China Cancer Biological Therapy Sales Volume Share by Application (2018-2023)
-
Table East China Cancer Biological Therapy Production Volume by Type (2018-2023)
-
Table East China Cancer Biological Therapy Production Volume Share by Type (2018-2023)
-
Figure East China Cancer Biological Therapy Production Volume Share by Type (2018-2023)
-
Table East China Cancer Biological Therapy Sales Volume by Application (2018-2023)
-
Table East China Cancer Biological Therapy Sales Volume Share by Application (2018-2023)
-
Figure East China Cancer Biological Therapy Sales Volume Share by Application (2018-2023)
-
Table Northeast China Cancer Biological Therapy Production Volume by Type (2018-2023)
-
Table Northeast China Cancer Biological Therapy Production Volume Share by Type (2018-2023)
-
Figure Northeast China Cancer Biological Therapy Production Volume Share by Type (2018-2023)
-
Table Northeast China Cancer Biological Therapy Sales Volume by Application (2018-2023)
-
Table Northeast China Cancer Biological Therapy Sales Volume Share by Application (2018-2023)
-
Figure Northeast China Cancer Biological Therapy Sales Volume Share by Application (2018-2023)
-
Table Southwest China Cancer Biological Therapy Production Volume by Type (2018-2023)
-
Table Southwest China Cancer Biological Therapy Production Volume Share by Type (2018-2023)
-
Figure Southwest China Cancer Biological Therapy Production Volume Share by Type (2018-2023)
-
Table Southwest China Cancer Biological Therapy Sales Volume by Application (2018-2023)
-
Table Southwest China Cancer Biological Therapy Sales Volume Share by Application (2018-2023)
-
Figure Southwest China Cancer Biological Therapy Sales Volume Share by Application (2018-2023)
-
Table Northwest China Cancer Biological Therapy Production Volume by Type (2018-2023)
-
Table Northwest China Cancer Biological Therapy Production Volume Share by Type (2018-2023)
-
Figure Northwest China Cancer Biological Therapy Production Volume Share by Type (2018-2023)
-
Table Northwest China Cancer Biological Therapy Sales Volume by Application (2018-2023)
-
Table Northwest China Cancer Biological Therapy Sales Volume Share by Application (2018-2023)
-
Figure Northwest China Cancer Biological Therapy Sales Volume Share by Application (2018-2023)
-
Table ELI Lilly Company Profile
-
Table ELI Lilly Cancer Biological Therapy Revenue, Price and Gross (2018-2023)
-
Table AstraZeneca, Plc Company Profile
-
Table AstraZeneca, Plc Cancer Biological Therapy Revenue, Price and Gross (2018-2023)
-
Table Seattle Genetics Company Profile
-
Table Seattle Genetics Cancer Biological Therapy Revenue, Price and Gross (2018-2023)
-
Table Roche Company Profile
-
Table Roche Cancer Biological Therapy Revenue, Price and Gross (2018-2023)
-
Table GlaxoSmithKline Company Profile
-
Table GlaxoSmithKline Cancer Biological Therapy Revenue, Price and Gross (2018-2023)
-
Table Takeda Pharmaceuticals Company Profile
-
Table Takeda Pharmaceuticals Cancer Biological Therapy Revenue, Price and Gross (2018-2023)
-
Table Pfizer Company Profile
-
Table Pfizer Cancer Biological Therapy Revenue, Price and Gross (2018-2023)
-
Table Spectrum Pharmaceuticals Company Profile
-
Table Spectrum Pharmaceuticals Cancer Biological Therapy Revenue, Price and Gross (2018-2023)
-
Table Merck Company Profile
-
Table Merck Cancer Biological Therapy Revenue, Price and Gross (2018-2023)
-
Table Abbvie Company Profile
-
Table Abbvie Cancer Biological Therapy Revenue, Price and Gross (2018-2023)
-
Table Novartis International Company Profile
-
Table Novartis International Cancer Biological Therapy Revenue, Price and Gross (2018-2023)
-
Table Bristol-Myers Squibb Company Profile
-
Table Bristol-Myers Squibb Cancer Biological Therapy Revenue, Price and Gross (2018-2023)
-
Table Eisai Company Profile
-
Table Eisai Cancer Biological Therapy Revenue, Price and Gross (2018-2023)
-
Table Incyte Company Profile
-
Table Incyte Cancer Biological Therapy Revenue, Price and Gross (2018-2023)
-
Table Sanofi Company Profile
-
Table Sanofi Cancer Biological Therapy Revenue, Price and Gross (2018-2023)
-
Table Amgen Company Profile
-
Table Amgen Cancer Biological Therapy Revenue, Price and Gross (2018-2023)
-
